Home     >     Business     >    

Angel Yeast Launches Premium Dry Yeast to Cater to Changing Global Baking Needs at Bakery China 2022

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Angel Yeast, (SH600298), the world's leading yeast manufacturer announces that it has developed the latest dry yeast product Premium Dry Yeast to address many of today's baking challenges at Bakery China 2022 -- a global largest event serving the entire value chain for the bakery and confectionery market.

These innovative yeasts meet the latest requirements of the baking industry for stability, convenience and overall adaptability, and Angel Yeast remains committed to continually introducing higher-quality products to help the industry grow and thrive.

With the widespread use of yeast in a variety of baking applications, yeast producers are faced with the objective challenge of creating formulations that meet the requirements of changing environments, the culinary customs of each region, as well as the expectations of different consumers. Premium Dry Yeast, the latest dry yeast developed by Angel, responds to the industry's latest requirements for baked goods.

The innovative advantages of Premium Dry Yeast include:

  • High-sugar yeast resistant to high osmotic pressure and weak organic acids

    Some traditional French croissants and brioche as well as Italian panettone have high sugar and oil content, and excess oil or sugar may affect yeast fermentation. Large-scale food producers need to extend the shelf life of their bread and baked goods, so they need yeast that is resistant to weak organic acids to meet this requirement. Angel Yeast's new Premium high-sugar dry yeast product is resistant to high sugar, high salt content and weak organic acids, overcoming this challenge and ensuring rapid, high-quality fermentation.

  • Resistance to cold shock

    Bakers in tropical climates must deal with high temperatures and harsh production environments. They need to add ice to control the dough temperature and avoid yeast fermentation that is too rapid.  Angel Yeast's new high and low-sugar yeasts are resistant to cold shock, meaning that they still allow standard fermentation that is critical in recipes that require the addition of ice and cold water despite the significantly lower temperatures.
  • Well-adapted and easy to use
    Harsh production conditions are another challenge for bakers worldwide. As a result, both mass-scale bakeries and home bakers seek high-quality, easy-to-use ingredients to maximize the overall appeal of their finished goods.  The introduction of this new and innovative yeast is a testament to Angel Yeast's dedication to improving the quality and adaptability of dry yeast in the absence of specialized equipment such as fermenters and mixers, even when dealing with poor flour quality.

The research and development (R&D) process of Angel Yeast's premium varieties of dry yeast has been comprehensive and responsive. Experimental phases have been designed for each application scenario, including high and low-temperature environments and different formulations. The formulations are then adjusted to improve the performance of the yeast based on the test results.

High-sugar yeast is designed for bakery products requiring recipes with 5%-30% sugar, while low-sugar yeast is suitable for baked goods made with recipes containing 0%-12% sugar. Angel Yeast's new low-sugar variety is more tolerant to sugar, not only feasible for low-sugar bread recipes, but also for fermenting high-sugar formulations.

Yeast producers select high-quality yeast strains from around the world and cultivate them in a variety of extreme environments through techniques such as adjusting the physiological parameters to produce yeasts that can tolerate different environments. One strain comes from the Himalayan region and is resistant to cold water, the second strain is resistant to heat and high temperatures, while a third strain, originating from a high-altitude, low-oxygen location, comes with a strong natural growth capacity and adaptability.

In addition, both yeast varieties have a water content of not more than 5%, translating into a longer, 24-month shelf life in a cool, dry place under regular storage conditions. Quality, safety and customer value are at the heart of Angel Yeast's culture and approach to yeast fermentation and development, and Angel Yeast's new premium dry yeast provides a much needed solution to today's global baking challenges and consumer expectations.

  • Media Contact
  • Angel Yeast
Information contained on this page is provided by an independent third-party content provider.This Site make no warranties or representations in connection therewith.If you are affiliated with this page and would like it removed it please contact service@ceapress.com
Related tags: Biotechnology,Food/Beverages,Health Care/Hospital

2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines

2022-06-19 10:30:00

After the 2014 and 2016 winners for the Tang Prize in Biopharmaceutical Sciences were crowned the Nobel Prize in 2018 and 2020 respectively, this category has continued to garner much attention worldwide. After much waiting, names of the latest winners were finally announced at ten in the morning of June 19. This year's award went to three scientists who played a critical role in the development of SARS-CoV-2 mRNA vaccines: Katalin Kariko, Drew Weissman, and Pieter Cullis, "for the discovery of key vaccinology concepts and approaches, leading to the successful development of mRNA-based COVID-19 vaccine," according to the selection committee's citation.

ASTRUM-005: Henlius Released Phase 3 Study Results for the First-line Treatment of Small Cell Lung Cancer of Serplulimab at ASCO 2022

2022-06-06 21:00:00

Shanghai Henlius Biotech, Inc. announced that an international randomized phase 3 study of HANSIZHUANG , an anti-PD-1 mAb independently developed by Henlius, as first-line treatment for extensive-stage small-cell lung cancer has been orally presented at 2022 American Society of Clinical Oncology Annual Meeting. Serplulimab is the first China-developed anti-PD-1 mAb in first-line treatment of lung cancer that was presented orally at ASCO Annual Meeting. The leading principal investigator is Professor Ying Cheng from Jilin Cancer Hospital.

Winner of Six Awards, Yili Further Elevated Its Profile as A World-Leading Innovator

2022-06-16 21:25:00

From June 14-16, the 15th Global Dairy Congress was hosted in Laval, France. Dr. Zhanyou Yun, Assistant President of Yili Group, attended the "Innovation for the Future" session, delivering a keynote speech with the theme "Create Value through Innovation." Dr. Gerrit Smit, Managing Director of Yili Innovation Center Europe, attended the roundtable discussion.

Angel Yeast Increases New Energy Procurement in Green Push to Curb Carbon Emission

2022-06-05 21:00:00

Angel Yeast , a listed global yeast and yeast extract manufacturer, is glad to announce that the Company has been granted the green electricity certificate issued and certified by China Hubei Power Exchange Center and China Hubei Carbon Emissions Exchange at a signing ceremony held in Hubei province, China. Angel Yeast is among the first 71 companies to be given the certificate in the province, as part of China's national scheme designed to drive the green transition and accelerate toward a circular economy.

Scientists take the first step to master an all-powerful cell type in the beginning of life

2022-06-21 23:10:00

Sheng Ding and his team at Tsinghua University School of Pharmaceutical Sciences publish innovative work in Nature

Infinitus co-organizes Norm Management Day Event in move to drive growth of the health food sector

2022-06-20 16:37:00

On June 16, Chinese herbal health products provider Infinitus Company Ltd. and Xinhuanet co-hosted the online 2022 Positive Energy Campaign for China's health food industry and the 6.16 Infinitus Norm Management Day Live Broadcast Sharing Event. This is the sixth year in a row that the company has hosted the event.